Related Experiment Videos
Alterations in thyroid function induced by chronic administration of amiodarone.
Drugs Under Experimental and Clinical Research
|January 1, 1987
Summary
Amiodarone treatment significantly alters thyroid function, reducing T3 and increasing reverse T3 (rT3) in heart disease patients. While T4 and FT4 may rise, clinical hyperthyroidism is rare, but hypothyroidism requires T4 level monitoring.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Amiodarone is an effective antiarrhythmic drug.
- Amiodarone is known to cause thyroid dysfunction.
- Understanding amiodarone's impact on thyroid hormones is crucial for patient management.
Purpose of the Study:
- To investigate the longitudinal effects of amiodarone on thyroid function in patients with heart disease.
- To differentiate between subclinical and overt thyroid dysfunction induced by amiodarone.
- To establish monitoring guidelines for amiodarone-induced thyroid alterations.
Main Methods:
- Prospective study of 50 heart disease patients treated with amiodarone (200-400 mg/day, 5 days/week).
- Thyroid function tests (T3, FT3, rT3, TSH, T4, FT4) were assessed over 16 months.
- Statistical analysis of data from 14 patients completing all scheduled examinations.
Main Results:
- Significant reduction in T3 and FT3 levels observed within 7 days, persisting at 12 and 16 months.
- Significant increase in reverse T3 (rT3) indicating low T3 syndrome.
- Thyroid-stimulating hormone (TSH) initially rose then fell below baseline.
- Elevated T4 and FT4 levels were common, but clinical hyperthyroidism occurred in only 6% of cases.
- Hypothyroidism diagnosis requires T4 reduction; isolated TSH increase is unreliable.
Conclusions:
- Amiodarone significantly alters thyroid hormone metabolism, primarily characterized by low T3 syndrome.
- Clinical monitoring for hyperthyroidism is essential, but subclinical changes are frequent.
- Diagnosis of amiodarone-induced hypothyroidism necessitates T4 level assessment.